Please Note: This medication is fulfilled by The Pharmacy Hub, a licensed 503A compounding pharmacy, using BPI Labs (503B) vials of Tirzepatide with Vitamin B6.

Commercial dose levels (2.5mg, 5mg, 7.5mg, etc.) are shown only as familiar reference points. Upon provider approval, prescriptions are written as custom compounded doses, tailored to your clinical needs and consistent with FDA guidance for compounded GLP-1s. Each prescription is reviewed by a licensed provider, verified by the pharmacy, and dispensed to provide the therapeutic equivalent of your selected treatment plan.

This 24-week (6 month) plan offers two paths depending on your clinical stage:

Option 1: 24-Week Titration Plan

For patients beginning treatment or increasing their dose, the titration plan provides a structured step-up dosing schedule over six months. Each 4-week step is designed to help your body adjust gradually while balancing effectiveness with tolerability.

Includes:

• A 24-week structured titration schedule (provider-directed escalation)
• Custom-compounded Tirzepatide with Vitamin B6
• Injection supplies for the full plan duration
• Licensed provider review and follow-up

Option 2: 24-Week Maintenance Plan

For patients who have already completed dose escalation, the maintenance plan provides steady therapy at a clinically appropriate flat dose. This option supports long-term stability and helps sustain weight loss results without additional titration.

Includes:

• 24 weeks of flat-dose therapy (provider-approved)
• Custom-compounded Tirzepatide with Vitamin B6
• Injection supplies for the full plan duration
• Licensed provider review and follow-up

This peptide blend may help support:

• Glucose regulation and metabolic efficiency
• Appetite signaling and satiety hormones
• Mitochondrial function and cellular repair
• Sustainable long-term health goals under medical guidance

Important Notice: This is a telehealth service. All treatments require submission of a medical intake form and are subject to licensed provider review and approval. Final dosage and pharmacy fulfillment will be determined at the medical evaluation. Products listed are compounded medications provided by licensed 503A or 503B pharmacy partners based on clinical need. These medications are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease.